Downregulation of DHODH sensitizes SCLC cell U1690 to TRAIL-mediated apoptosis, and BRQ possesses significantly lower toxicity toward U1690 cells, which would be optimal for a combinatorial therapy [41, 69]. The gene discussed is DHODH; the disease is small cell lung carcinoma.